Chang-ik Choi

Goyang, Republic of Korea

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 53 publications

Fat Browning Effects of Catalpol and Rhoifolin from Rehmannia glutinosa (Gaertn.) and Lonicera japonica (Thunb.) in 3T3-L1 Adipocytes via the β3-AR Signaling Pathway.

Fat Browning Effects of Catalpol and Rhoifolin from Rehmannia glutinosa (Gaertn.) and Lonicera japonica (Thunb.) in 3T3-L1 Adipocytes via the β3-AR Signaling Pathway.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: April 16, 2026

Hydramethylnon induces synergistic toxicity of pyrethroid mixtures in human lung epithelial cells.

Hydramethylnon induces synergistic toxicity of pyrethroid mixtures in human lung epithelial cells.

Journal: Toxicological research

Published: January 31, 2026

Coixol and Sinigrin from Coix lacryma-jobi L. and Raphanus sativus L. Promote Fat Browning in 3T3-L1 Adipocytes.

Coixol and Sinigrin from Coix lacryma-jobi L. and Raphanus sativus L. Promote Fat Browning in 3T3-L1 Adipocytes.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: October 10, 2025

Nutritional Composition, Phytochemical Profiles, and Pharmacological Effects of Ethiopian Eggplant (Solanum aethiopicum L.).

Nutritional Composition, Phytochemical Profiles, and Pharmacological Effects of Ethiopian Eggplant (Solanum aethiopicum L.).

Journal: Nutrients

Published: November 01, 2024

Hederagenin from Hedera helix Promotes Fat Browning in 3T3-L1 Adipocytes.

Hederagenin from Hedera helix Promotes Fat Browning in 3T3-L1 Adipocytes.

Journal: Plants (Basel, Switzerland)

Published: August 30, 2024

Effects of fluconazole on the pharmacokinetics of celecoxib and its carboxylic acid metabolite in different CYP2C9 genotypes.

Effects of fluconazole on the pharmacokinetics of celecoxib and its carboxylic acid metabolite in different CYP2C9 genotypes.

Journal: Archives of pharmacal research

Published: March 30, 2024

Physiologically based pharmacokinetic (PBPK) modeling of pitavastatin in relation to SLCO1B1 genetic polymorphism.

Physiologically based pharmacokinetic (PBPK) modeling of pitavastatin in relation to SLCO1B1 genetic polymorphism.

Journal: Archives of pharmacal research

Published: November 10, 2023

PBPK modeling to predict the pharmacokinetics of pantoprazole in different CYP2C19 genotypes.

PBPK modeling to predict the pharmacokinetics of pantoprazole in different CYP2C19 genotypes.

Journal: Archives of pharmacal research

Published: November 10, 2023

PBPK modeling to predict the pharmacokinetics of venlafaxine and its active metabolite in different CYP2D6 genotypes and drug-drug interactions with clarithromycin and paroxetine.

PBPK modeling to predict the pharmacokinetics of venlafaxine and its active metabolite in different CYP2D6 genotypes and drug-drug interactions with clarithromycin and paroxetine.

Journal: Archives of pharmacal research

Published: November 09, 2023

Betanin from Beetroot (Beta vulgaris L.) Regulates Lipid Metabolism and Promotes Fat Browning in 3T3-L1 Adipocytes.

Betanin from Beetroot (Beta vulgaris L.) Regulates Lipid Metabolism and Promotes Fat Browning in 3T3-L1 Adipocytes.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: November 08, 2023

Physiologically based pharmacokinetic (PBPK) modeling to predict the pharmacokinetics of irbesartan in different CYP2C9 genotypes.

Physiologically based pharmacokinetic (PBPK) modeling to predict the pharmacokinetics of irbesartan in different CYP2C9 genotypes.

Journal: Archives of pharmacal research

Published: November 07, 2023

Physiologically based pharmacokinetic (PBPK) modeling of gliclazide for different genotypes of CYP2C9 and CYP2C19.

Physiologically based pharmacokinetic (PBPK) modeling of gliclazide for different genotypes of CYP2C9 and CYP2C19.

Journal: Archives of pharmacal research

Published: October 26, 2023

Showing 1-12 of 53

Last Updated: 09/26/2026